<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(3)</volume><submitter>Korean Association for the Study of the Liver (KASL)</submitter><journal>Clinical and molecular hepatology</journal><pagination>542-592</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10366804</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>KASL clinical practice guidelines for management of autoimmune hepatitis 2022.</pubmed_title><pmcid>PMC10366804</pmcid><pubmed_authors>Korean Association for the Study of the Liver (KASL)</pubmed_authors></additional><is_claimable>false</is_claimable><name>KASL clinical practice guidelines for management of autoimmune hepatitis 2022.</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jul</publication><modification>2025-04-22T13:32:35.378Z</modification><creation>2025-04-06T00:41:24.935Z</creation></dates><accession>S-EPMC10366804</accession><cross_references><pubmed>37137334</pubmed><doi>10.3350/cmh.2023.0087</doi></cross_references></HashMap>